1 most recent filing and news item mentioning TYR. Updated every 60 seconds.
RestructuringJul 31, 2026Negative
aTyr Pharma terminated a 2020 collaboration agreement with Kyorin Pharmaceutical effective July 30, 2026. The development partner exercised its termination rights, ending work on the licensed product.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.